$ATRS, $GTXI, $ASTX, $TSRX, $KERX, plus macro and market commentary, and outlook for the upcoming trading week.
Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included.
Solta will be acquired soon, Here is Why
In August of 2012, I wrote an article detailing why Obagi Medical Products would be acquired soon. Obagi was under pressure from Voce Capital Management to sell the company. Obagi resisted acquisition interest for a time, until Voce and other…
Public Video: | Market Wrap-Up and Commentary For 7.17.13 + Previewing 2 Upcoming Picks
Hi everyone, Scotty here with ya! In this video, I give my view on recent market action, my short/mid/long term forecast moving forward, Biotech stock commentary, and a preview of 2 picks from stockmatusow.com for next week. Premium members get…
Video:|Market Commentary with Charts and Opinion, 7/16/13
Some stock charts reviewed along with my market forecast and commentary for the rest of this week. $TSRX $KERX $GTXI $ATRS $SPY covered. Watch out for min correction based on macro headlines from Europe concerning Spain and Portugal.
Premium Members Only:| July 13.2013 Market Commentary Forecast For Next Week
July 13th, 2013 Market Commentary and Forecast For Next Week; In this video, I give my views on last week’s small cap market movement, and offer various market forecast opinions moving forward. I mention $TSRX, $ATRS, $FB, $GTXI, and others.…
Video: My Trius (TSRX) chart opinion as of market close 7/11/2013
Video: My Trius (TSRX) chart opinion as of market close 7/11/2013
Corrected Video: Market Commentary + Trade Watch Update 7/13/13
Some commentary from me on recent market action plus chart commentary on some of our recent picks. $GTXI $TSRX $SGMO $DRRX $SGMO $FB $BBY
Udated: Catalyst run-up pick – Astex Pharmaceuticals (ASTX)
Catalyst pick – Astex Pharmaceuticals (ASTX) Price Target opinion = $5.50- $5.75 Evaluating risk-to-reward ratio is one key tenant to becoming a successful investor. Investors who are able to limit risk, while increasing the chances of reaping rewards usually make…
4 Biopharmas On Catalyst Watch List For Week 7/8/2013
Stockmatusow.com has compiled 4 biopharmas with significant near-term catalysts ahead that should drive their respective stock prices higher. We think each of these companies should also be looked at for speculation investments. Since the companies listed below are smaller caps,…
